Stent Patents (Class 623/23.7)
-
Patent number: 8070825Abstract: The present invention is an endo-prostatic stent and a detachable catheter apparatus including the same, allowing the correct positioning of the stent using tactile feed-back of the operator during insertion i.e. without the need for any imaging means like endoscopy or sonography.Type: GrantFiled: May 23, 2006Date of Patent: December 6, 2011Inventor: Marian Devonec
-
Patent number: 8066715Abstract: A medical device and method for its use in the digestive system of a mammalian patient is provided. The medical device includes a stent and a retrieval device. The stent has a magnetic element connected to an end of the stent. The retrieval device includes a magnetic member, and the retrieval device is sized to be ingested by the patient. The magnetic member is capable of being magnetically coupled to the magnetic element of the stent for removal of the stent through the natural forces of the digestive system.Type: GrantFiled: October 3, 2007Date of Patent: November 29, 2011Assignee: Cook Medical Technologies LLCInventor: Richard W. Ducharme
-
Publication number: 20110282461Abstract: Disclosed herein is a stent implanted in the body of a patient. The stent includes a hollow cylindrical stent body which is made of a super-elastic shape memory alloy and has an expanded diameter part on one end thereof, and a support stent which has an elastic spherical structure and is fitted over the cylindrical stent body behind the expanded diameter part. The stent is implanted in the body such that food that has passed through the stomach is prevented from mixing with bile or pancreatic juice in the duodenum and moves directly into the small intestine to prevent the duodenum from absorbing nutrients of the food while the small intestine directly digests the food and absorbs the nutrients, thus minimizing a nutrient absorption rate, thereby preventing the obesity of the patient.Type: ApplicationFiled: April 27, 2011Publication date: November 17, 2011Inventors: Kyong-Min SHIN, Byung-Cheol Myung
-
Patent number: 8057461Abstract: A stent is designed to be placed in a lumen of a patient and extend therethrough. The stent includes a distal end and a proximal end. The distal end includes a distal retention structure and the proximal end includes a plurality of radially extending flexible segments to prevent migration of the stent through the lumen. At least one radially extending flexible segment at the proximal end is able to assume an outwardly everted configuration. The stent of the invention, due to its dimensions, shape, and rigidity, minimizes the force of contact and abrasion to sensitive areas of the patient's body, such as the trigone region of the bladder and the ureteral-vesical junction.Type: GrantFiled: April 2, 2008Date of Patent: November 15, 2011Assignee: Boston Scientific Scimed, Inc.Inventor: Travis Deal
-
Patent number: 8055360Abstract: A system and method of aligning a stent with a stent support involves taking two images of the stent that has been placed on the stent support and determining from the two images whether the stent is aligned with the stent support. The stent can be rotated so that the two images are of different views of the stent. A computer can be configured to receive the images and to determine the whether the stent is aligned. A backlight can be used to take images of the stent in silhouette. A portion of the stent support can be re-positioned based on an image taken of the stent.Type: GrantFiled: October 23, 2010Date of Patent: November 8, 2011Assignees: Abbott Cardiovascular Systems Inc., ATS Automation Tooling Systems Inc.Inventors: Sang joon Park, Shaulaine Choo, Anthony S. Andreacchi, Yung-Ming Chen, Arnoldo M. Currlin, Antonio Garcia, Jason Van Sciver, Thomas David Esbeck, Bryan D. Glenn
-
Publication number: 20110270405Abstract: In at least one embodiment, the invention is directed to an endoluminal device comprising a stent and a sleeve. In one embodiment, the endoluminal device is implanted in a portion of the gastrointestinal tract. In some embodiments, the stent has a first region and a second region where the first and second regions provide different levels of radial force. In one embodiment, the first region is made from a plurality of first wires having a first diameter and the second region is made from a plurality of second wires having a second diameter which is smaller than the first diameter. In other embodiments, the endoluminal device has at least one engagement mechanism engaging the stent to the sleeve, the endoluminal device to a body lumen, and any combination thereof. In at least one embodiment, the endoluminal device has a wall with at least one opening therein.Type: ApplicationFiled: April 18, 2011Publication date: November 3, 2011Applicant: BOSTON SCIENTIFIC SCIMED, INC.Inventors: Kurt Geitz, Claude Clerc
-
Publication number: 20110270406Abstract: The anti-obesity stent includes a tubular structure having outer and inner surfaces and proximal and distal ends. The tubular structure is sized to fit within a duodenum in substantially coaxial relation therewith. The tubular structure is impervious or semi-permeable to digestive substances and chyme within the duodenum. The anti-obesity stent includes a transport structure at least a part of which is coincident with or connected to the outer surface. The transport structure extends to the distal end of the tubular structure. At least one retainer structure is connected to the tubular structure. The retainer structure secures the tubular structure within the duodenum such that the transport structure is positioned to receive digestive fluids from a papilla of Vater on an inner surface of the duodenum. The transport structure provides a conduit for the digestive fluids therein to flow to the distal end.Type: ApplicationFiled: July 8, 2011Publication date: November 3, 2011Applicant: BOSTON SCIENTIFIC SCIMED, INC.Inventors: Barry Weitzner, Taryn Deneault, Katie Krueger, Claude Clerc, Harold M. Martins, William Bertolino
-
Patent number: 8048171Abstract: According to one aspect of the invention, ureteral stents are provided that comprise an elongated stent body and a urologically beneficial agent. The elongated stent body comprises a kidney portion adapted to occupy the kidney of a subject upon implantation, a ureter portion adapted to occupy the ureter of a subject upon implantation, and a bladder portion adapted to occupy the bladder of a subject upon implantation. The ureteral stents of the invention are adapted to release the urologically beneficial agent into the subject. Moreover, the amount of urologically beneficial agent that is released varies along the length of the stent. Other aspects of the invention pertain to methods of forming such stents and methods of using such stents.Type: GrantFiled: March 26, 2009Date of Patent: November 1, 2011Assignee: Boston Scientific Scimed, Inc.Inventor: Jianmin Li
-
Publication number: 20110251670Abstract: An expandable stent that can transform between a collapsed state and an expanded state is described. The stent includes a first cross-sectional shape and a second cross-sectional shape. The first cross-sectional shape is a non-convex shape when the stent is in the collapsed state. Alternatively, the second cross-sectional shape is a convex shape when the stent is in an expanded state. The stent can be formed of super elastic Nitinol, which allows it to be shape set in the desired shape. Due to its shape setting properties and the non-convex cross-section, the stent is capable of dramatically reducing its cross-sectional radial profile which is beneficial in a variety of procedures.Type: ApplicationFiled: April 7, 2011Publication date: October 13, 2011Inventors: Arash Kheradvar, Morteza Gharib
-
Patent number: 8034119Abstract: A medical stent provides an active agent to a patient's body while simultaneously maintaining an open passageway within the body of the patient. The stent includes a first segment, a second segment, a connecting segment disposed between the first and second segments, and the active agent. The active agent may be a hemostatic agent that stops or controls bleeding by coagulation, or any other medical drug, such as, for example an antibiotic or an anticoagulant. When the stent is properly positioned within the patient's urinary system, the first segment is located on one side of the external sphincter and the second segment is located on the other side. The connecting segment is sized to extend through the external sphincter to couple the first and second segments together while not interfering with the normal operation of the external sphincter.Type: GrantFiled: December 23, 2008Date of Patent: October 11, 2011Assignee: Boston Scientific Scimed, Inc.Inventor: Kenneth P. Reever
-
Publication number: 20110245912Abstract: Radiopaque, iodinated, absorbable polyesters, polyester urethanes, and polyether-ester-urethanes with and without inorganic iodide micro-/nanoparticles dispersed or solubilized therein, and composite inorganic iodide micro-/nanoparticles in an absorbable polyester, polyester-urethane, polyester-ester, or polyether-ester urethane matrix are employed in medical devices and therapeutic compositions.Type: ApplicationFiled: April 6, 2010Publication date: October 6, 2011Inventors: Shalaby W. Shalaby, Kenneth David Gray
-
Publication number: 20110230974Abstract: An airway stent with an integral suture anchor is used to prevent migration of the stent within the airway. The suture anchor is incorporated by percutaneous placement of a suture through the neck and into the stent. The distal end of the suture includes an anchor element to secure the suture to the stent. The opposite end of the suture is tensioned and held in place by a suture clamp and a pledget routed over the stent and placed against the neck. Airway stents such as tracheal stents are effective at maintaining airway patency however; a common complication is stent migration. The integral suture anchor provides a reliable, economical, and non-intrusive solution to stent migration.Type: ApplicationFiled: March 9, 2011Publication date: September 22, 2011Applicant: NATIONAL JEWISH HEALTHInventor: Ali I. MUSANI
-
Patent number: 8021414Abstract: A stent in a non-expanded state has a first and second expansion column, each consisting of a plurality of expansion strut pairs. An expansion strut pair includes a first expansion strut, a second expansion strut and a joining strut that couples the first and second expansion struts at one end. Expansion strut pairs include expansion strut pair first and second corners formed where the joining strut couples the first and second expansion struts. A connecting strut column, formed of a plurality of connecting struts couples the first and second expansion columns. Connecting struts include a proximal section, a distal section and an intermediate section. The proximal section is coupled to the corner of an expansion strut pair of the first expansion column, and the distal section is coupled to the joining strut of an expansion strut pair of the second expansion column intermediate the expansion strut pair first corner and the expansion strut pair second corner.Type: GrantFiled: July 25, 2002Date of Patent: September 20, 2011Assignee: Boston Scientific Scimed, Inc.Inventor: G. David Jang
-
Patent number: 8021434Abstract: A stent is designed to be placed within a patient's ureter to facilitate drainage from the patient's kidneys to the bladder. An elongated portion of the stent includes a length sufficient to extend substantially within the ureter from the kidney to the bladder, and defines a lumen extending therethrough. A first end portion extends from one end of the elongated portion and is adapted to assume a retaining configuration when placed substantially within the kidney. A second end portion extends from another end of the elongated portion and flares outward when placed substantially within the bladder to maintain position. The second end portion allows fluids to flow through the lumen and into the bladder and is collapsible to prevent fluid from passing from the bladder to the kidney.Type: GrantFiled: February 3, 2005Date of Patent: September 20, 2011Assignee: Boston Scientific Scimed, Inc.Inventors: Joseph Segura, James Teague
-
Patent number: 8007702Abstract: A method includes forming an elongated member having a tubular shape. The elongated member includes a sidewall that defines a lumen. A spiral-shaped opening is formed in the sidewall such that the elongated member is configured to move between a retracted configuration and an expanded configuration along a longitudinal axis of the lumen. In some embodiments, the method further includes forming a distal retention structure. The distal retention structure can be disposed at a distal end of the elongated member and can define a lumen in fluid communication with the lumen defined by the sidewall of the elongated member.Type: GrantFiled: December 1, 2009Date of Patent: August 30, 2011Assignee: Boston Scientific Scimed, Inc.Inventor: Barry N. Gellman
-
Patent number: 8007541Abstract: The present invention relates to a stent for introduction into a hollow organ, in particular the gastrointestinal tract, of a human or animal patient, which brings about vacuum sealing of leaks, such as anastomosis insufficiencies, in the hollow organ.Type: GrantFiled: March 11, 2010Date of Patent: August 30, 2011Assignee: MNET GmbH Medizinische DatensystemeInventors: Stefan Benz, Frank Pfeffer
-
Patent number: 8002731Abstract: The anti-obesity stent includes a tubular structure having outer and inner surfaces and proximal and distal ends. The tubular structure is sized to fit within a duodenum in substantially coaxial relation therewith. The tubular structure is impervious or semi-permeable to digestive substances and chyme within the duodenum. The anti-obesity stent includes a transport structure at least a part of which is coincident with or connected to the outer surface. The transport structure extends to the distal end of the tubular structure. At least one retainer structure is connected to the tubular structure. The retainer structure secures the tubular structure within the duodenum such that the transport structure is positioned to receive digestive fluids from a papilla of Vater on an inner surface of the duodenum. The transport structure provides a conduit for the digestive fluids therein to flow to the distal end.Type: GrantFiled: May 30, 2006Date of Patent: August 23, 2011Assignee: Boston Scientific Scimed, Inc.Inventors: Barry Weitzner, Taryn Deneault, Katie Krueger, Claude Clerc, Harold M. Martins, William Bertolino
-
Patent number: 7997266Abstract: Methods and devices are disclosed for manipulating the airway, such as to treat obstructive sleep apnea. An implant is positioned within the body with respect to the airway. The spatial orientation of the airway is manipulated, directly or indirectly, to affect the configuration of the airway. In general, the implant is manipulated to displace the trachea in an inferior direction, resist superior displacement of the trachea and/or to alter the tracheal wall tension. The implant restrains the trachea in the manipulated configuration.Type: GrantFiled: October 4, 2004Date of Patent: August 16, 2011Assignee: Koninklijke Philips Electronics N.V.Inventors: Andrew Frazier, Chad C. Roue, Michael T. Dineen, Erik J. van der Burg
-
Patent number: 7992566Abstract: An apparatus and methods for treating sleep apnea and/or snoring are provided. The apparatus includes an appliance sized and structured to be placed in the pharyngeal region of a human or animal. The appliance, when so placed is effective in treating sleep apnea and/or snoring, for example in maintaining openness of an oropharyngeal region of a human or animal during natural sleep. Preferably, the appliance is non-circumferential in form and includes rounded, spaced apart end portions.Type: GrantFiled: July 22, 2003Date of Patent: August 9, 2011Assignee: Quiescence Medical, Inc.Inventors: D. Russell Pflueger, Christopher Paul Thompson
-
Patent number: 7993411Abstract: An implantable drainage device for treatment of a stricture of a body vessel is disclosed. The device comprises a drainage tube including an inlet and extending to an outlet to define a drainage lumen formed through the inlet and the outlet. The drainage tube includes a swell layer and a cast layer formed about the swell layer. The swell layer has a first agent dispersed thereabout for regulated drug elution through the cast layer. The cast layer has a second agent disposed thereabout for drug elution therefrom.Type: GrantFiled: August 29, 2008Date of Patent: August 9, 2011Assignee: Cook Medical Technologies LLCInventors: Kenneth C. Kennedy, II, Wenfeng Lu, Brian K. Rucker, Vihar C. Surti
-
Publication number: 20110178370Abstract: A system of rotate-to-advance medical devices including catheters, dilators, occluders, stents, suprapubic catheters and camera introducers configured with external screw threads and depending substantially on rotation for means of advancement and emplacement in mammalian genitourinary and gastrointestinal passages and organs.Type: ApplicationFiled: October 5, 2010Publication date: July 21, 2011Inventor: James J. Frassica
-
Publication number: 20110171272Abstract: According to an aspect of the invention, urological medical devices are provided, which comprise a prostatically beneficial agent selected from alpha-adrenergic blockers, antispasmodic agents, anticholinergic/antimuscarinic agents, calcium channel blockers, anti-inflammatory agents, hormone affecting agents, anti-cancer agents, and combinations thereof, among others. The urological medical devices are adapted for implantation or insertion into a subject's urinary tract, whereupon at least a portion of the prostatically beneficial agent is released into the subject's prostatic urethra. The release profile of the prostatically beneficial agent is effective to treat a prostatic disorder, for example, benign prostate hypertrophy, prostate cancer or prostatitis, among others. Other aspects of the invention are directed to treating prostatic disorders.Type: ApplicationFiled: March 14, 2011Publication date: July 14, 2011Applicant: Boston Scientific Scimed, Inc.Inventors: Jianmin Li, Min-Shyan Sheu, Weenna Bucay-Couto
-
Patent number: 7976488Abstract: A collapsible gastrointestinal anchor can be characterized in various embodiments by a radial force of about 0.1 Newtons (N) or greater at a compressed diameter of 25 millimeters (mm); by an average spring rate of about 13 Newtons/meter (N/m) or greater in a range of motion between a relaxed diameter and a compressive elastic deformation diameter; or by a radial force over the range of motion of about 0.1 N or greater. Typically, the anchor can be adapted to be retained within a subject's intestine, more typically in the duodenum, or particularly in the duodenal bulb just distal to the pylorus. A gastrointestinal implant device includes the collapsible gastrointestinal anchor and a floppy sleeve. The sleeve is open at both ends and adapted to extend into a subject's intestine, the anchor being coupled to a proximal portion of the sleeve. Also include are methods of implanting the gastrointestinal implant device in a subject, and methods of treating a subject for disease.Type: GrantFiled: June 8, 2005Date of Patent: July 12, 2011Assignee: GI Dynamics, Inc.Inventors: Andy H. Levine, David A. Melanson
-
Publication number: 20110153027Abstract: A drug delivery medical device such as a gastrointestinal stent comprises a support 1 which has an outer cover or coating 2. The cover or coating comprises a plurality of patches or tiles 3 of a polymeric material which contain a drug. The patches 3 form a continuous or discontinuous mosaic. The patches may be held together using a biodegradable adhesive.Type: ApplicationFiled: December 17, 2010Publication date: June 23, 2011Applicant: Vysera Biomedical LimitedInventor: Niall Behan
-
Publication number: 20110153004Abstract: A method of forming a coating on a medical device having a controlled morphology is described. A method of treating a disorder in a patient using the medical device is described.Type: ApplicationFiled: February 28, 2011Publication date: June 23, 2011Applicant: Advanced Cardiovascular Systems, Inc.Inventors: LOTHAR WALTER KLEINER, JESSICA RENEE DESNOYER, STEPHEN DIRK PACETTI, SYED FAIYAZ AHMED HOSSAINY
-
Patent number: 7951188Abstract: The invention is directed to an expandable stent for implantating in a body lumen, such as a coronary artery, peripheral artery, or other body lumen. The invention provides for a an intravascular stent having a plurality of cylindrical rings connected by undulating links. The stent has a high degree of flexibility in the longitudinal direction, yet has adequate vessel wall coverage and radial strength sufficient to hold open an artery or other body lumen.Type: GrantFiled: May 15, 2003Date of Patent: May 31, 2011Assignee: Abbott Cardiovascular Systems Inc.Inventors: Stephen D. Ainsworth, E Tina Cheng, James M. Jacobs
-
Patent number: 7951206Abstract: A medical stent is sized for placement in a ureter. The stent includes a first section which includes a first material, defines a lumen, and includes a first coil completing at least one revolution. A second section of the stent includes a second material, defines a lumen, and includes a second coil completing at least one revolution. A third section defines a lumen and is located between the first and second sections. The third section includes a co-extrusion of the first and second materials. One of the first or second sections is harder than the other section.Type: GrantFiled: November 5, 2007Date of Patent: May 31, 2011Assignee: Boston Scientific Scimed, Inc.Inventor: Ernest J. St. Pierre
-
Publication number: 20110098825Abstract: Disclosed herein is a stent for prostatic urethra expansion which does not generate bladder stones, is removable without causing injury on a urethra, and does not generate atrophy of a prostatic urethra even after removal. The stent for prostatic urethra expansion include a stent unit including a cylindrical body with space parts formed by knotting or crossing shape memory alloy wires and bending terminals formed at both ends of the cylindrical body, a pair of hook wires passing through the space parts and knotted to the shape memory alloy wires, both ends thereof being wound on the bending terminals and then being bent upwardly to produce hooks, and a pair of hanging strings arranged in opposite directions to form a hanging knot. The stent for prostatic urethra expansion does not move into the bladder, and expands and maintains a lumen of the stenosed prostatic urethra, thereby reducing post-operative recovery time.Type: ApplicationFiled: September 28, 2010Publication date: April 28, 2011Inventors: Kyong-Min SHIN, Jeung-Hee Nam, Kang-Sun Hong, Ho-Young Song, Tae-Hyung Kim
-
Publication number: 20110093002Abstract: A variety of stent arrangements are described in which multiple stents expand and coordinate to block the spaces between the struts of the outer stent to create a tubular stent not prone to tissue in-growth. One or more stents are selectively positioned within an outer stent such that the struts of the one or more stents at least partially fill the openings of the outer stent. Alternatively, the one or more stents may be permanently affixed to the outer stent to produce a stent arrangement in which the openings between the struts of the outer stent are blocked by the struts of the one or more stents.Type: ApplicationFiled: October 20, 2009Publication date: April 21, 2011Applicant: Wilson-Cook Medical Inc.Inventors: Brian K. Rucker, Caroline M. Gayzik
-
Patent number: 7927621Abstract: A poly(thioester ester amide) copolymer and method of making and using the same are disclosed.Type: GrantFiled: June 25, 2007Date of Patent: April 19, 2011Assignee: Abbott Cardiovascular Systems Inc.Inventors: Mikael O. Trollsas, Nam D. Pham, Michael H. Ngo, Bozena Zofia Maslanka
-
Publication number: 20110087336Abstract: The self-expanding plastic stent is a resilient plastic stent with such expansional strength that a small diameter delivery system may be used to implant the stent, thereby minimizing possible complications for the patient. The stent is made from a braided monofilament, which may be polyetheretherketone (PEEK), polyetherketone (PEK), polyetherketoneketone (PEKK), polyaryletherketone (PAEK), polyetherketoneether-ketoneketone (PEKEKK), or any blends and alloys of these particular resins. The plastic stent may or may not be covered with polymer film. When used, the polymer film includes materials based on polyurethanes, silicones, or materials that biodegrade or erode in the body. Specifically the biodegradable materials might include poly-L-lactide, poly-D-lactide, polyglycolide, ?-caprolactone (epsilon-caprolactone), starch, and collagen or its polymer blends, alloys or copolymers. This material is heat-treated. The monofilament preferably has a diameter of 0.2-0.7 mm.Type: ApplicationFiled: October 8, 2010Publication date: April 14, 2011Inventors: PETR KUBENA, LUCIE KOTALOVA
-
Publication number: 20110087252Abstract: A stent and a method for implanting a stent for decompression and anastomosis formation are provided. The stent includes a non-expandable, generally tubular body having a proximal portion and a distal portion, a lumen extending through at least a portion of the body, a distal opening in the distal portion in fluid communication with the lumen and a proximal opening in the proximal portion in fluid communication with the lumen. The stent further includes a first magnetic element positioned on the distal portion of the tubular body and a second magnetic element movably positionable on the proximal portion of the tubular body. The second magnetic element is configured to surround and move over the proximal portion of the tubular body towards the first magnetic element.Type: ApplicationFiled: October 8, 2009Publication date: April 14, 2011Applicant: Wilson-Cook Medical Inc.Inventor: Kevin Chmura
-
Patent number: 7922684Abstract: The anti-obesity dual stent includes a tubular outer structure within which is located a coaxial tubular inner structure. The outer structure is sized to fit within a duodenum in substantially coaxial relation therewith. The outer and inner structures communicate with the pylorus and papilla of Vater to provide conduits for the chyme and digestive fluid. Alternatively, the anti-obesity dual stent may include a tubular papilla-supplied structure which has a lateral orientation relative to a tubular pylorus-supplied structure. The papilla-supplied and pylorus-supplied structures each are sized to fit longitudinally within the duodenum. The pylorus-supplied and papilla-supplied structures communicate with the pylorus and papilla of Vater to provide conduits for the chyme and digestive fluid.Type: GrantFiled: May 30, 2006Date of Patent: April 12, 2011Assignee: Boston Scientific Scimed, Inc.Inventors: Barry Weitzner, Katie Krueger, Claude Clerc, William Bertolino
-
Patent number: 7923022Abstract: An implantable medical device is disclosed comprising: a structural element, wherein the structural element includes: a continuous phase comprising a first polymer of LPLG; a discrete phase within the continuous phase, wherein the discrete phase comprises a second polymer including rapidly eroding elastic discrete phase segments. The second polymer further includes anchor segments that have the same or substantially the same chemical make up as the first polymer of the continuous phase, and at least some of the anchor segments have partially or completely phase-separated from the discrete phase into the continuous phase.Type: GrantFiled: September 13, 2006Date of Patent: April 12, 2011Assignee: Advanced Cardiovascular Systems, Inc.Inventors: Yunbing Wang, David C. Gale
-
Patent number: 7909789Abstract: Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within Schlemm's canal and maintains the patency of the canal without substantially interfering with transmural fluid flow across the canal. The devices utilize the natural drainage process of the eye and can be implanted with minimal trauma to the eye. Kits include a support and an introducer for implanting the support within Schlemm's canal. Methods include implanting a support within Schlemm's canal, wherein the support is capable of maintaining the patency of the canal without substantial interference with transmural fluid flow across the canal.Type: GrantFiled: June 26, 2006Date of Patent: March 22, 2011Assignee: Sight Sciences, Inc.Inventors: David Y. Badawi, Paul Badawi
-
Publication number: 20110066251Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.Type: ApplicationFiled: June 22, 2010Publication date: March 17, 2011Applicant: ANGIOTECH PHARMACEUTICALS, INC.Inventors: William L. HUNTER, Lindsay S. Machan, A. Larry Arsenault
-
Publication number: 20110034993Abstract: Coated medical devices are disclosed. In certain embodiments of the invention, the coating materials include therapeutic agents, polymers, sugars, waxes, or fats. In certain embodiments of the invention, a medical device is coated on at least a portion of its surface with a first coating comprising a therapeutic agent and a wax or fat. The coated medical device may be a stent or catheter.Type: ApplicationFiled: August 13, 2010Publication date: February 10, 2011Applicant: BOSTON SCIENTIFIC SCIMED, INC.Inventors: Marlene Schwarz, Kathleen Miller, Kalpana Kamath
-
Publication number: 20110009941Abstract: A device including a self-expandable member having a proximal end portion and a main body portion. Each of the self-expandable portions consists of a plurality of cell structures formed by intersecting strut members. In one implementation, at least one proximal cell structure in the proximal end portion has one or more struts that have a width and/or thickness greater than the width and/or thickness of the majority of strut members in the main body of the expandable member. In another implementation at least some of the intersecting strut members have a thickness to width ratio of greater than one. Attached to at least one of the proximal-most cell structures in the proximal end portion is a proximally extending flexible wire having sufficient length and flexibility to navigate the tortuous vasculature of a patient. In another implementation, the device is delivered to the treatment site through the lumen of a delivery catheter.Type: ApplicationFiled: December 21, 2009Publication date: January 13, 2011Applicant: CONCENTRIC MEDICAL, INC.Inventors: Ryan M. Grandfield, Scott D. Wilson, John H. Miller, Emily Vu, Kirk L. Pedersen, Craig L. Bonsignore, Elliot H. Sanders
-
Patent number: 7853340Abstract: A method for aligning a stent with a stent support includes the steps of (1) placing a stent support and a stent mounted on the stent support in a vertically position with the stent support's first support element at a lower position and the stent support's second support element at an upper position; (2) obtaining a digital image of the stent support and stent; (3) analyzing the digital image of the stent support and stent to compute the vertical position of the stent's upper end; (4) computing a desired position of the second support element based on the position of the stent's upper end; and (5) using a positioning device to move the second support element to the desired position. The movement of the second support element causes the conical sections of the first and second support elements to engage the respective ends of the stent to center the stent around a core element of the stent support and to secure the stent in a longitudinal direction of the stent support.Type: GrantFiled: September 11, 2009Date of Patent: December 14, 2010Assignees: Abbott Cardiovascular Systems Inc., ATS Automation Tooling Systems Inc.Inventors: Sang joon Park, Shaulaine Choo, Anthony S. Andreacchi, Yung-Ming Chen, Arnoldo M. Currlin, Antonio Garcia, Jason Van Sciver, Thomas David Esbeck, Bryan D. Glenn
-
Publication number: 20100298948Abstract: An energy delivery probe is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply energy to tissue, such as a prostrate, to shrink, damage, denaturate the prostate. In some embodiments, the energy can be applied with a vapor media. Another feature of the energy delivery probe is that it can deploy a stent to apply tissue-compressive forces to the prostate tissue after energy delivery. Methods associated with use of the energy delivery probe are also covered.Type: ApplicationFiled: April 27, 2010Publication date: November 25, 2010Inventors: Michael Hoey, John H. Shadduck
-
Patent number: 7837643Abstract: Methods and systems for delivering or placing a gastrointestinal implant device into a mammal. The gastrointestinal implant device can be used to limit absorption of food products in specific parts of the digestive system and can include a gastrointestinal sleeve having an anchor portion and a barrier or sleeve portion. The methods include endoluminal delivery of the device.Type: GrantFiled: February 14, 2005Date of Patent: November 23, 2010Assignee: GI Dynamics, Inc.Inventors: Andy H. Levine, David A. Melanson, Ronald B. Lamport
-
Patent number: 7837645Abstract: An endoscopic device separates ingested food from gastric fluids or gastric fluids and digestive enzymes, to treat obesity. In a particular embodiment a gastric bypass stent comprises a tubular member and two or more stent members defining a lumen. The tubular member has a substantially liquid impervious coating or covering and one or more lateral openings to permit one-way liquid flow.Type: GrantFiled: March 5, 2007Date of Patent: November 23, 2010Assignee: The Trustees of Columbia University in the City of New YorkInventors: Marc Bessler, John D. Allendorf
-
Patent number: 7833282Abstract: Devices are provided for insertion into a Eustachian tube of an animal, e.g., a human being. The devices may include an insertable member, an immobilizing means and a fluid-communication providing means. The member has opposing surfaces and is formed at least in part from a biocompatible material that is degradable. The fluid-communication providing means is effective to provide sufficient fluid communication between the opposing surfaces of the insertable member to effect pressure equilibration therebetween. The immobilizing means is effective to immobilize the device within the Eustachian tube for a predetermined period. Also provided are kits that include the device and methods for inserting the device into a Eustachian tube.Type: GrantFiled: February 26, 2007Date of Patent: November 16, 2010Inventor: Aditi H. Mandpe
-
Patent number: 7833280Abstract: A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.Type: GrantFiled: April 8, 2008Date of Patent: November 16, 2010Assignee: Barosense, Inc.Inventors: Richard S. Stack, Richard A. Glenn, Trevor J. Moody, Fred E. Silverstein, Nathan Every, William S. Eubanks, Jr.
-
Patent number: 7833281Abstract: A system and method for delivering one or more implantable members, such as metal coils, via an introducer member, such as an endoscopic needle, into a space created within the submucosal layers of the LES to augment and bulk the sphincter to improve compliance in patients with gastroesophageal reflux disease. The implantable member comprises a first substantially straightened configuration when carried by the introducer member, whereby it assumes a more curvilinear or coiled configuration following deployment such that it expands against adjacent submucosal tissue, creating a bulge at the implantation site. In another embodiment, the implantable member can serve as an anchoring port for sutures or other elements introduced for gastroplication of the LES to create tissue folds that increase sphincter compliance. The implantable members may be configured to include an external portion that interconnects with an adjacent implantable member, thereby creating tension that also increases compliance of the LES.Type: GrantFiled: December 15, 2005Date of Patent: November 16, 2010Inventors: Glen A. Lehman, Brian K. Rucker
-
Publication number: 20100286791Abstract: Provided are methods and apparatus for the use of magnetic traction to maintain the patency of a tubular anatomical structure, whether a vessel, duct, the trachea, bronchus, bile duct, ureter, vas deferens, fallopian tube, or portions of the digestive tract, as to constitute means for extraluminal stenting. An extraluminal stent consists of a perimedial or medial intravascular and an extravascular component. The intravascular component consists of ferromagnetic spherules implanted aeroballistically or stays implanted by means of a special hand tool, while the extravascular component consists of a pliant jacket or mantle that has magnets mounted about its outer surface.Type: ApplicationFiled: November 19, 2007Publication date: November 11, 2010Inventor: David S. Goldsmith
-
Publication number: 20100256772Abstract: A system is provided for preventing the accumulation of cumulative matter from clogging a stent, such as a plastic tubular drainage stent for use in the biliary system. The system includes a stent having one or more magnetically reactive objects moveably disposed therein and an actuation device, such as a glove, having one or more magnets thereon. When the actuation device is waived near the one or more magnetically reactive objects of the stent, it actuates them by manually manipulating the one or more magnetically reactive objects of the stent by attracting or repelling them such that they contact the stent walls dislodging cumulative matter attached thereto. As a result of the system, the stent is able to remain resident within the patient for an extended period of time before becoming clogged and needing to be replaced.Type: ApplicationFiled: April 1, 2010Publication date: October 7, 2010Applicant: Wilson-Cook Medical Inc.Inventor: Gregory J. Skerven
-
Patent number: 7799088Abstract: A porous weave of bioabsorbable filaments having an open mesh configuration is formed into an oblate shape having dimensions greater than the esophageal opening and gastric outlet of a stomach. The resulting prosthesis is deployed in the stomach and is of a size to be retained in the proximate portion thereof for exerting pressure on the upper fundus. The prosthesis limits the amount of food that may be held within the stomach, and exerts pressure on the fundus to create a sensation of being full, resulting in weight loss.Type: GrantFiled: August 10, 2006Date of Patent: September 21, 2010Assignee: Boston Scientific Scimed, Inc.Inventor: Kurt Geitz
-
Patent number: 7789848Abstract: Methods and devices for use in tissue approximation and fixation are described herein. The present invention provides, in part, methods and devices for acquiring tissue folds in a circumferential configuration within a hollow body organ, e.g., a stomach, positioning the tissue folds for affixing within a fixation zone of the stomach, preferably to create a pouch or partition below the esophagus, and fastening the tissue folds such that a tissue ring, or stomas, forms excluding the pouch from the greater stomach cavity. The present invention further provides for a liner or bypass conduit which is affixed at a proximal end either to the tissue ring or through some other fastening mechanism. The distal end of the conduit is left either unanchored or anchored within the intestinal tract. This bypass conduit also includes a fluid bypass conduit which allows the stomach and a portion of the intestinal tract to communicate.Type: GrantFiled: March 5, 2007Date of Patent: September 7, 2010Assignee: Satiety, Inc.Inventors: Jamy Gannoe, Craig Gerbi, Gary Weller, Matthew J. Collier
-
Patent number: 7789915Abstract: A stent is made from a coiled wire and is very smooth along its length and as well its ends. The stent is thus highly atraumatic to patients, and because of its smooth surfaces, it presents a surface to which it is difficult for microbes to cling. The stent may be used in a minimally invasive procedure, such as for a ureteral stent, and may also be used percutaneously. Similar stents may be used in other body areas, such as in draining the biliary tract, the gastro-intestinal tract, hepatic procedures, and in vascular procedures as well.Type: GrantFiled: May 14, 2007Date of Patent: September 7, 2010Assignees: Vance Products Incorporated, Cook Ireland LimitedInventors: Shay Lavelle, Jessica W. Miller